Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Non-Current Debt (2009 - 2026)

Evotec SE's (EVO) quarterly Non-Current Debt came in at $481.6 million in Q2 2026, up 19.77% year-over-year from $402.1 million in Q2 2025, and up 37.65% quarter-over-quarter from $349.9 million in Q1 2026.

Analysis

Evotec SE (EVO) Non-Current Debt (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Non-Current Debt across 9 years of filings, most recently posting $481.6 million for Q2 2026.

  • In Q2 2026, Non-Current Debt rose 19.77% year-over-year to $481.6 million; the TTM figure through Jun 2026 stood at $481.6 million (up 19.77% YoY), while the FY2025 annual figure was $388.7 million, down 8.57% from the prior year.
  • Non-Current Debt came in at $481.6 million for Q2 2026 at Evotec SE, up from $349.9 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $513.3 million in Q4 2023 to a low of -$349.7 million in Q2 2022.
  • Average Non-Current Debt over 5 years is $370.0 million, with a median of $418.1 million recorded in 2023.
  • Year-over-year, Non-Current Debt soared 219.11% in 2023 and declined 20.39% in 2026.
  • Over 5 years, Non-Current Debt stood at $500.2 million in 2022, then advanced by 2.62% to $513.3 million in 2023, then dropped by 18.25% to $419.7 million in 2024, then decreased by 4.59% to $400.4 million in 2025, then increased by 20.27% to $481.6 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Debt figures were $481.6 million in Q2 2026, $349.9 million in Q1 2026, and $400.4 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 13.71 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn -
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 2.62 Bn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn 2.11 Bn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 1.04 Bn
6 Evotec SE 642.83 Mn 216.96 Mn - 481.59 Mn
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn -
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn -
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn -
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 481.59 Mn
Mar 31, 2026 349.87 Mn
Dec 31, 2025 400.44 Mn
Sep 30, 2025 453.29 Mn
Jun 30, 2025 402.09 Mn
Mar 31, 2025 439.47 Mn
Dec 31, 2024 419.68 Mn
Sep 30, 2024 457.42 Mn
Dec 31, 2023 513.34 Mn
Jun 30, 2023 416.52 Mn
Dec 31, 2022 500.22 Mn
Sep 30, 2022 329.48 Mn
Jun 30, 2022 -349.70 Mn
Mar 31, 2022 366.01 Mn
Dec 31, 2021 373.33 Mn
Sep 30, 2021 374.92 Mn
Dec 31, 2020 394.67 Mn
Sep 30, 2010 3.87 Mn
Jun 30, 2010 3.82 Mn
Mar 31, 2010 5,007.11